Cellular and T cell engager Immunotherapy
Identifying immune checkpoints on dysregulated T-cells as prognostic biomarkers for multiple myeloma patients with COVID-19
Ziping Li, PhD candidate (she/her/hers)
Resident physician
Department of Hematology, Peking Union Medical College Hospital , Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China, China (People's Republic)